Company Interview / High hopes: ECS Botanics secures loan for growth

Nan-Maree Schoerie of ECS Botanics (ASX: ECS) shares that the company has secured a $5.2 million loan facility from NAB. This funding will support ECS in expanding its B2C segment and launching its new turf product line. She appreciates the funding as it aids in rapid business growth.

Nan-Maree highlights ECS's transition from a predominantly B2B to a balanced B2C model, requiring more working capital. The secured contract with Californian brand Tupac's for the 'Z' genetics promises expansion in Australia, New Zealand, UK and Germany markets. ECS aims to leverage the loan to support this significant growth.

Despite the challenges in the global trade landscape, ECS Botanics remains optimistic. Nan-Maree notes the company's resilience to current tariffs, though they impact market sentiment. She emphasizes ECS's potential in the cannabis industry, with long-term opportunities still ahead.